Diosynth is a company that develops manufacturing processes for active ingredients for pharmaceutical companies all over the world. The company started in 1923 with the extraction of insulin from bovine pancreas, which is still one of their main products. As of January 1, 2005, this company is a part of Organon.
 |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
